Landscape Capital Management’s Emergent Biosolutions EBS Stock Holding History

Landscape Capital Management’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-13,322	Closed	-$118K	–	777
2025 Q3	$118K	Sell	13,322 -3,188	-19%	-$24.8K	0.01%	576
2025 Q2	$105K	Sell	16,510 -7,085	-30%	-$40.5K	0.01%	606
2025 Q1	$115K	Hold	23,595	–	–	0.01%	582
2024 Q4	$226K	Buy	23,595 +6,682	+40%	+$61.3K	0.02%	564
2024 Q3	$141K	Buy	+16,913	New	+$154K	0.01%	597
2016 Q3	–	Sell	-7,643	Closed	-$215K	–	476
2016 Q2	$215K	Buy	+7,643	New	+$300K	0.03%	483
2016 Q1	–	Sell	-13,800	Closed	-$552K	–	636
2015 Q4	$552K	Buy	13,800 +1,670	+14%	+$58.2K	0.07%	418
2015 Q3	$346K	Sell	12,130 -3,470	-22%	-$114K	0.05%	424
2015 Q2	$514K	Buy	+15,600	New	+$484K	0.09%	326

Other funds holding EBS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

OHA

Oak Hill Advisors New York $878M AUM 106.46% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

PCM

Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Landscape Capital Management's EBS Position: Q4 2025 in Review

Landscape Capital Management sold out of Emergent Biosolutions (EBS) in Q4 2025, closing a stake of 13,322 shares — an estimated $118K sold.

Landscape Capital Management first reported a position in EBS in Q2 2015 and held it in 9 quarters. The position peaked at $552K in Q4 2015. 183 funds tracked by Wall St. Rank hold EBS as of Q4 2025.

Landscape Capital Management reported no remaining Emergent Biosolutions position as of Q4 2025 after selling out during the quarter.
Landscape Capital Management sold 13,322 Emergent Biosolutions shares in Q4 2025, an estimated $118K.
Landscape Capital Management first reported a position in Emergent Biosolutions in Q2 2015 and held it in 9 quarters.
Landscape Capital Management's Emergent Biosolutions position peaked at $552K in Q4 2015.
183 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q4 2025.

Based on Landscape Capital Management's 13F filing for Q4 2025, filed 13 Feb 2026.